2024-04-012025-03-312025-03-31false08246397COASTAL ORTHOPAEDICS LIMITED2025-12-23falseiso4217:GBPxbrli:pure082463972024-03-31082463972025-03-31082463972024-04-012025-03-31082463972023-03-31082463972024-03-31082463972023-04-012024-03-3108246397bus:SmallEntities2024-04-012025-03-3108246397bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3108246397bus:FullAccounts2024-04-012025-03-3108246397bus:PrivateLimitedCompanyLtd2024-04-012025-03-3108246397core:WithinOneYear2025-03-3108246397core:AfterOneYear2025-03-3108246397core:WithinOneYear2024-03-3108246397core:AfterOneYear2024-03-3108246397core:ShareCapital2025-03-3108246397core:SharePremium2025-03-3108246397core:RevaluationReserve2025-03-3108246397core:OtherReservesSubtotal2025-03-3108246397core:RetainedEarningsAccumulatedLosses2025-03-3108246397core:ShareCapital2024-03-3108246397core:SharePremium2024-03-3108246397core:RevaluationReserve2024-03-3108246397core:OtherReservesSubtotal2024-03-3108246397core:RetainedEarningsAccumulatedLosses2024-03-3108246397core:LandBuildings2025-03-3108246397core:PlantMachinery2025-03-3108246397core:Vehicles2025-03-3108246397core:FurnitureFittings2025-03-3108246397core:OfficeEquipment2025-03-3108246397core:NetGoodwill2025-03-3108246397core:IntangibleAssetsOtherThanGoodwill2025-03-3108246397core:ListedExchangeTraded2025-03-3108246397core:UnlistedNon-exchangeTraded2025-03-3108246397core:LandBuildings2024-03-3108246397core:PlantMachinery2024-03-3108246397core:Vehicles2024-03-3108246397core:FurnitureFittings2024-03-3108246397core:OfficeEquipment2024-03-3108246397core:NetGoodwill2024-03-3108246397core:IntangibleAssetsOtherThanGoodwill2024-03-3108246397core:ListedExchangeTraded2024-03-3108246397core:UnlistedNon-exchangeTraded2024-03-3108246397core:LandBuildings2024-04-012025-03-3108246397core:PlantMachinery2024-04-012025-03-3108246397core:Vehicles2024-04-012025-03-3108246397core:FurnitureFittings2024-04-012025-03-3108246397core:OfficeEquipment2024-04-012025-03-3108246397core:NetGoodwill2024-04-012025-03-3108246397core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108246397core:ListedExchangeTraded2024-04-012025-03-3108246397core:UnlistedNon-exchangeTraded2024-04-012025-03-3108246397core:MoreThanFiveYears2024-04-012025-03-3108246397core:Non-currentFinancialInstruments2025-03-3108246397core:Non-currentFinancialInstruments2024-03-3108246397dpl:CostSales2024-04-012025-03-3108246397dpl:DistributionCosts2024-04-012025-03-3108246397core:LandBuildings2024-04-012025-03-3108246397core:PlantMachinery2024-04-012025-03-3108246397core:Vehicles2024-04-012025-03-3108246397core:FurnitureFittings2024-04-012025-03-3108246397core:OfficeEquipment2024-04-012025-03-3108246397dpl:AdministrativeExpenses2024-04-012025-03-3108246397core:NetGoodwill2024-04-012025-03-3108246397core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108246397dpl:GroupUndertakings2024-04-012025-03-3108246397dpl:ParticipatingInterests2024-04-012025-03-3108246397dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3108246397core:ListedExchangeTraded2024-04-012025-03-3108246397dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3108246397core:UnlistedNon-exchangeTraded2024-04-012025-03-3108246397dpl:CostSales2023-04-012024-03-3108246397dpl:DistributionCosts2023-04-012024-03-3108246397core:LandBuildings2023-04-012024-03-3108246397core:PlantMachinery2023-04-012024-03-3108246397core:Vehicles2023-04-012024-03-3108246397core:FurnitureFittings2023-04-012024-03-3108246397core:OfficeEquipment2023-04-012024-03-3108246397dpl:AdministrativeExpenses2023-04-012024-03-3108246397core:NetGoodwill2023-04-012024-03-3108246397core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108246397dpl:GroupUndertakings2023-04-012024-03-3108246397dpl:ParticipatingInterests2023-04-012024-03-3108246397dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3108246397core:ListedExchangeTraded2023-04-012024-03-3108246397dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3108246397core:UnlistedNon-exchangeTraded2023-04-012024-03-3108246397core:NetGoodwill2025-03-3108246397core:IntangibleAssetsOtherThanGoodwill2025-03-3108246397core:LandBuildings2025-03-3108246397core:PlantMachinery2025-03-3108246397core:Vehicles2025-03-3108246397core:FurnitureFittings2025-03-3108246397core:OfficeEquipment2025-03-3108246397core:AfterOneYear2025-03-3108246397core:WithinOneYear2025-03-3108246397core:ListedExchangeTraded2025-03-3108246397core:UnlistedNon-exchangeTraded2025-03-3108246397core:ShareCapital2025-03-3108246397core:SharePremium2025-03-3108246397core:RevaluationReserve2025-03-3108246397core:OtherReservesSubtotal2025-03-3108246397core:RetainedEarningsAccumulatedLosses2025-03-3108246397core:NetGoodwill2024-03-3108246397core:IntangibleAssetsOtherThanGoodwill2024-03-3108246397core:LandBuildings2024-03-3108246397core:PlantMachinery2024-03-3108246397core:Vehicles2024-03-3108246397core:FurnitureFittings2024-03-3108246397core:OfficeEquipment2024-03-3108246397core:AfterOneYear2024-03-3108246397core:WithinOneYear2024-03-3108246397core:ListedExchangeTraded2024-03-3108246397core:UnlistedNon-exchangeTraded2024-03-3108246397core:ShareCapital2024-03-3108246397core:SharePremium2024-03-3108246397core:RevaluationReserve2024-03-3108246397core:OtherReservesSubtotal2024-03-3108246397core:RetainedEarningsAccumulatedLosses2024-03-3108246397core:NetGoodwill2023-03-3108246397core:IntangibleAssetsOtherThanGoodwill2023-03-3108246397core:LandBuildings2023-03-3108246397core:PlantMachinery2023-03-3108246397core:Vehicles2023-03-3108246397core:FurnitureFittings2023-03-3108246397core:OfficeEquipment2023-03-3108246397core:AfterOneYear2023-03-3108246397core:WithinOneYear2023-03-3108246397core:ListedExchangeTraded2023-03-3108246397core:UnlistedNon-exchangeTraded2023-03-3108246397core:ShareCapital2023-03-3108246397core:SharePremium2023-03-3108246397core:RevaluationReserve2023-03-3108246397core:OtherReservesSubtotal2023-03-3108246397core:RetainedEarningsAccumulatedLosses2023-03-3108246397core:AfterOneYear2024-04-012025-03-3108246397core:WithinOneYear2024-04-012025-03-3108246397core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3108246397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3108246397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3108246397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3108246397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3108246397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3108246397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108246397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108246397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108246397core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3108246397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3108246397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3108246397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3108246397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3108246397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3108246397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3108246397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3108246397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3108246397core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3108246397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3108246397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3108246397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3108246397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3108246397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3108246397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3108246397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3108246397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3108246397bus:Director12024-04-012025-03-3108246397bus:Director22024-04-012025-03-3108246397core:FurnitureFittingsToolsEquipment2024-03-3108246397core:FurnitureFittingsToolsEquipment2024-04-012025-03-3108246397core:FurnitureFittingsToolsEquipment2025-03-31

COASTAL ORTHOPAEDICS LIMITED

Registered Number
08246397
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

COASTAL ORTHOPAEDICS LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

CROOK, Timothy Bernard
WILLIAMS, Lucy Alyness Prentice

Registered Address

1st Floor, Buckley House 31a The Hundred
Romsey
SO51 8GD

Registered Number

08246397 (England and Wales)
COASTAL ORTHOPAEDICS LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets327,19334,739
27,19334,739
Current assets
Debtors31,91127,917
Current asset investments498,74695,191
Cash at bank and on hand577,134453,328
707,791576,436
Creditors amounts falling due within one year5(87,274)(86,422)
Net current assets (liabilities)620,517490,014
Total assets less current liabilities647,710524,753
Net assets647,710524,753
Capital and reserves
Called up share capital150150
Profit and loss account647,560524,603
Shareholders' funds647,710524,753
The financial statements were approved and authorised for issue by the Board of Directors on 23 December 2025, and are signed on its behalf by:
CROOK, Timothy Bernard
Director
Registered Company No. 08246397
COASTAL ORTHOPAEDICS LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20252024
Average number of employees during the year00
3.Tangible fixed assets

Vehicles

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 April 2444,7801,2126,45852,450
Additions-2481,3341,582
At 31 March 2544,7801,4607,79254,032
Depreciation and impairment
At 01 April 2411,1957365,78017,711
Charge for year8,3961296039,128
At 31 March 2519,5918656,38326,839
Net book value
At 31 March 2525,1895951,40927,193
At 31 March 2433,58547667834,739
4.Current asset investments
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables-2,155
Taxation and social security76,86751,261
Other creditors7,46830,066
Accrued liabilities and deferred income2,9392,940
Total87,27486,422